The Single-Domain Antibody Platform Market is projected to be valued at US$ 22 Mn in 2020, and is expected to witness an impressive CAGR of around 10% during the forecast period 2022 – 2028. Single domain antibodies are an alternative to monoclonal antibodies due to their small size, low production cost, and potent inhibitors of immune and viral diseases. […]
